IMMX vs GILD: Which Stock is Better?
Side-by-side comparison of Immix Biopharma Inc and Gilead Sciences Inc in 2026
IMMX
Immix Biopharma Inc
$9.85
GILD
Gilead Sciences Inc
$140.45
Key Metrics Comparison
| Metric | IMMX | GILD | Winner |
|---|---|---|---|
| Market Cap | $513.69M | $172.56B | GILD |
| P/E Ratio | N/A | 20.51 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze IMMX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMMX or GILD a better investment?
Comparing IMMX and GILD: Immix Biopharma Inc has a market cap of $513.69M while Gilead Sciences Inc has $172.56B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMMX and GILD?
IMMX (Immix Biopharma Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMMX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMMX or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for IMMX.
Which company is more profitable: IMMX or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for IMMX.
Which is the larger company: IMMX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $172.56B compared to $513.69M for IMMX.
Should I buy IMMX or GILD in 2026?
Both IMMX and GILD have investment merit. IMMX trades at $9.85 while GILD trades at $140.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMMX and GILD stock?
Key differences: Market Cap ($513.69M vs $172.56B), P/E Ratio (N/A vs 20.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).